To the best of our knowledge, there has not been a large-scale randomized controlled trial (RCT) that has examined whether differences in basal GLP-1 levels resulted in different renal protection effects to GLP-1 RAs in T2DM patients. Here, GLP1R is linked to type 2 diabetes mellitus.